Atsushi Ishiguro

机构：Teine Keijinkai Hospital

发表论文 161 篇 · 总被引 1098 次 · h-index 18

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 98)
• Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07 (2021 · Gastric Cancer · 被引 92)
• Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08) (2021 · Gastric Cancer · 被引 36)
• Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study (2022 · Frontiers in Oncology · 被引 24)
• Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603 (2022 · The Oncologist · 被引 23)